A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.

Visit SirenInteractive.com to learn more.

Please email Frieda Hernandez for inquiries for more information.

Adventures in eMarketing

Sign up for the monthly enewsletter to receive:

  • The latest pharma and interactive trends
  • Insight into building relationships with rare disease communities
  • The latest news in health care, marketing and the internet
  • Thought-leadership you can’t afford to miss
View a sample newsletter Sign Up for
Adventures in eMarketing

#SocPharm on Twitter

See past #SocPharm transcripts

Blog Roll

Tag Cloud

Pharma Social Media Case Studies

Posted by Eileen O'Brien | 6:14 pm on Wednesday December 14, 2011 | 19 Comments

Share this article:

That's 10,800 units of Allegra sold coming from the Facebook page 

Last week I spoke at the Advanced Learning Institute’s Social Media for Pharma conference in New York City. “The pharma paradox is everybody wants to be innovative but nobody wants to be first,” said cochair, WPP’s Bill Evans. What was great about this intimate event was the specific case studies shared that offered examples for other companies. I’m going to highlight a few that resonated with me.

Facebook Page Contributes to Bottom Line
Shermon McMillan, Senior Marketing Manager from Chattem, a Sanofi Company, and William Martino from Saatchi & Saatchi Wellness discussed Allegra’s marketing efforts during the transition to over-the-counter. As part of their strategy, the Allegra team created a Facebook page with an open wall to communicate with their large target audience. The team has all of the content preapproved by medical/legal, and they work 2-3 months ahead. They have a variety of frequently asked questions, standard responses and thanks messages pre-approved. Many of these are also used for Allegra’s Twitter account. The brand team promoted the social media tools via ads, including Facebook ads.

Read More

Online Privacy & How to Encourage Opt-Ins

Posted by Eileen O'Brien | 6:29 pm on Monday December 05, 2011 | No Comments

Share this article:

computer keyboard with the word privacy on return key

respondents wanted a clear understanding of how they'll benefit from giving up data 

How much private information are you willing to share online? It probably depends upon who is asking, what you are getting in return and how much value it has to you. McCann Truth Central performed a quantitative study on privacy including 6,525 global consumers in July 2011 across 6 markets – UK, USA, Hong Kong, Japan, India, and Chile.

The researchers discovered a new understanding of the word privacy. “…‘privacy’ is a complex, multi-dimensional issue that encompasses everything from personal, real-world snooping to sharing data online. Further, when it comes to data sharing one must unpack the issue even further as consumers categorize data into different categories, e.g. shopping, location, personal, medical, and financial, and have varying degrees of concern with sharing each type.”

While the study found anxiety about the potential threats to reputation and finances, consumers were accepting of the use of personal data (including the text of emails) to serve up targeted ads online. And there was good news for pharma: pharma ranks among the industries that  survey respondents trust most to safeguard their data – behind only banks and credit card and medical companies.

Read More